MIRXES
MiRXES offers discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all.
MIRXES
Industry:
Biotechnology Health Care Life Science
Founded:
2014-01-01
Status:
Active
Contact:
6779 7340
Total Funding:
168 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Current Employees Featured
Zou Ruiyang Co-Founder & Chief Technology Officer @ MiRXES
Co-Founder & Chief Technology Officer
2015-01-01
Isaac Ho Chief Investment Officer @ MiRXES
Chief Investment Officer
Choo Beng Lor Chief Financial Officer @ MiRXES
Chief Financial Officer
Zhou Lihan Co-Founder & Chief Executive Officer @ MiRXES
Co-Founder & Chief Executive Officer
Founder
Investors List
Charoen Pokphand Group
Charoen Pokphand Group investment in Series C - MiRXES
Keytone Ventures
Keytone Ventures investment in Series C - MiRXES
Rock Springs Capital
Rock Springs Capital investment in Series C - MiRXES
CR-CP Life Science Fund
CR-CP Life Science Fund investment in Series C - MiRXES
CCB International
CCB International investment in Series C - MiRXES
New Horizons Venture Capital
New Horizons Venture Capital investment in Series C - MiRXES
CDG Capital
CDG Capital investment in Series C - MiRXES
EDBI
EDBI investment in Series C - MiRXES
EDBI
EDBI investment in Series C - MiRXES
Keytone Ventures
Keytone Ventures investment in Series C - MiRXES
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-03-31 | Med247 | MiRXES investment in Series A - Med247 | 4.5 M USD |
More informations about "MiRXES"
About - MiRXES
ABOUT From Singapore for the world Our Purpose Our mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. We are a Singapore-headquartered RNA technology company that is a …See details»
Mirxes - Crunchbase Investor Profile & Investments
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic …See details»
Infectious Diseases - MiRXES
The MiRXES R&D team is constantly tracking the World Health Organization’s designation of new VOCs and VOIs and has performed in silico analyses to determine the sequence homology between the MiRXES SARS-CoV2 RT …See details»
MiRXES 2025 Company Profile: Valuation, Funding
MiRXES General Information Description. Developer of a diagnostic test platform designed to detect cancer at an asymptomatic stage. The company …See details»
Mirxes | Genomic Services | Next-Generation …
Let Mirxes make the most of your genomics data—generated by us or by another sequencing partner—with bioinformatics services tailored to your research needs and budget. Learn More. Blog. April 23, 2025 Mirxes AACR Poster …See details»
Setting the Standard in Genomics for Quality & Value
As part of Mirxes Pte Ltd., we bring the strength of a global leader in biotechnology innovation to every project we undertake. With access to world-class facilities and industry-leading scientific expertise, Mirxes has the …See details»
Mirxes - Funding, Financials, Valuation & Investors - Crunchbase
Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection. New. Resources. Advanced Search. Start Free Trial . ... How much funding …See details»
Mirxes : Driving Early Detection | Healthcare Outlook
Feb 11, 2025 Mirxes is a Singapore-headquartered BioTech specialising in RNA-powered diagnostics and therapeutics and operates across APAC and the US with a strong network of …See details»
MiRXES Company Profile - Office Locations, Competitors, Revenue …
MiRXES is a biotech company focused on microRNA research and applications. It provides life science research and in vitro diagnostic (IVD) products. The company also offers a microRNA …See details»
Mirxes Secures $40M Investment for Cancer Detection …
Jan 13, 2025 Mirxes, a leading Singapore-based cancer detection firm, has secured $40 million in financing from CBC Group's R-Bridge Fund to enhance its innovative miRNA technology platform. The investment aims to support …See details»
Newsroom - MiRXES
May 13, 2024 Singapore – 11 June 2024 – Mirxes is pleased to announce that our fully-owned subsidiary, Mirxes Japan, has secured a grant of up to 20 million yen (S$172,000) from the …See details»
MiRXES Pte Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Jul 7, 2023 Mirxes is a biotech firm specializing in identifying, creating, and distributing precise preventative healthcare solutions for ailments such as cancer, cardiovascular disease, …See details»
MiRXES Japan Co., Ltd. | Success Stories - Why Invest - Investing in ...
MiRXES, a Singaporean company providing life science products and services such as liquid biopsy testing products for early diagnosis and precision medicine, and PCR testing for the …See details»
Mirxes’ CEO on why it’s HK over SG for its listing - Tech in Asia
Aug 25, 2023 That said, Mirxes CEO Zhou Lihan says that Hong Kong offers a better valuation and a more savvy investor pool. Playing catch up: It makes sense when you look at Hong …See details»
Mission, Vision & Core Values of Mirxes – CanvasBusinessModel.com
Oct 2, 2024 Mirxes Mission, Vision & Core Values Mirxes is dedicated to fostering innovation and excellence in all aspects of our organization. Our mission is to provide cutting-edge …See details»
Mirxes posts US$58 million operating loss, US$24 million revenue
May 9, 2024 SINGAPORE biotech firm Mirxes reported a 36.2 per cent year-on-year revenue growth to US$24.2 million in 2023, according to its April filing with the Hong Kong Stock …See details»
New policy tools and traditional policy models: better …
Apr 24, 2025 2. Understanding the two basic kinds of procedural and substantive policy tools. Understanding the impact of new policy tools requires recognizing, as the traditional literature …See details»
Careers - MiRXES
CAREERS Join the MiRXES Team Be part of the team delivering world-leading multi-cancer early detection. MiRXES is a Singapore-headquartered biotechnology company that translates …See details»
Listen: R.E.M. Release New “Radio Free Europe” Mixes to Benefit …
May 2, 2025 Calling out in transit: R.E.M. have announced a limited edition re-release of their groundbreaking debut single to raise funds for Radio Free Europe/Radio Liberty. Celebrating …See details»
MiRXES' Pandemic Pivot Pays Off - MiRXES
NEWSROOM Stay current with MiRXES Newsroom > Insights MiRXES’ Pandemic Pivot Pays Off Armed with a wealth of experience from the pandemic, MiRXES is now set to return to its roots …See details»